· NCI Surgery Director Steven Rosenberg After Ph.D. tumor immunotherapy
· 16+ year antibody new drug research and development experience. American Strong Pharmaceutical Chief Scientist and Senior Project Leader; Participate in Erbitux R & D and successful listing; leading multiple anti-cancer antibody new drug research, two of which enters the clinic
· Master of Hematology, Tongji Medical College, Ph.D., University of Northern Texas, United States
